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Abstract: In this paper, we report on a general synthetic strategy
for the assembly of glycopolymers that capitalizes on the intrinsic
reactivity of reducing glycans toward hydrazides to form stable
cyclic N-glycosides. We developed a poly(acryloyl hydrazide)
(PAH) scaffold to which we conjugated a variety of reducing
glycans ranging in structure from simple mono- and disaccharides
to considerably more complex human milk and blood oligosac-
charides. The conjugation proceeds under mild conditions with
excellent ligation efﬁciencies and in a stereoselective manner,
providing glycopolymers with pendant glycans accommodated
mostly in their cyclic -glycosidic form. Utilizing a biotin-terminated
PAH scaffold prepared via RAFT polymerization, we quickly
assembled a panel of glycopolymers that we microarrayed on
streptavidin-coated glass. We then demonstrated that in these
microarrays, the glycopolymer ligands bind lectins according to
the structures of their pendant glycans. Importantly, glycopolymers
containing biologically relevant branched oligosaccharides, such
as sialyl Lewisx, as well as sulfated glycosaminoglycan-like
epitopes can be readily prepared using our methodology.
Glycopolymers are an important class of synthetic macromol-
ecules that emulate many structural and functional features of cell-
surface glycoproteins.
1 These glycoproteins perform key regulatory
functions in many essential biological processes, such as innate
immunity, cellular communication, and pathogen invasion.
2 With
mounting evidence that not only the molecular structure but also
the valency and spatial organization of carbohydrate epitopes in
glycoproteins inﬂuence the speciﬁcity and avidity of their interac-
tions with cognate receptors,
3 glycopolymers have increasingly
served as a tool for probing the underlying mechanisms of these
events.
4 In addition, we have been interested in using glycopolymer
mimetics of mucin glycoproteins to control the presentation of
carbohydrates in glycan microarrays,
5 which have emerged as a
powerful platform for interrogating ligand speciﬁcities of carbo-
hydrate-binding proteins.
6
Although many inventive approaches for the synthesis of
glycopolymers have been developed,
1 none is particularly suitable
for the rapid, high-throughput assembly of glycopolymer libraries
we envisioned for our microarrays. Currently, two general synthetic
strategies exist for the generation of glycopolymers that bear glycans
in their native form (i.e., as closed cyclic pyranosides appended to
the polymer scaffold through a glycosidic linkage). One strategy
relies on polymerization of glycan-containing monomers,
7 while
the other is based on attachment of appropriately prefunctionalized
glycosides to polymer backbones endowed with complementary
reactive groups.
8 Both approaches require chemical elaboration of
the glycan component, which makes introduction of complex
glycans into glycopolymers synthetically challenging and time-
consuming.
Free reducing sugars, which are often available from natural
sources, react with R-heteroatom nucleophiles (e.g., hydrazide or
alkylaminooxy groups) to give cyclic pyranoside adducts in
predominantly -anomeric form.
9 In fact, this intrinsic reactivity
of carbohydrates has been skillfully employed in numerous ap-
plications, including glycan capture for structural and functional
glycomics,
10 assembly of synthetic glycoconjugates,
11 and im-
mobilization of sugars in glycan arrays.
12
Here we report a general strategy for the synthesis of glyco-
polymers that is based on the ligation of free reducing sugars to an
acryloyl hydrazide polymer scaffold. This approach eliminates the
inconvenience and limitations of laborious carbohydrate prefunc-
tionalization presently required for glycopolymer synthesis and
offers rapid access to glycopolymers with a broad scope of glycan
structures suitable for high-throughput microarray applications.
We synthesized biotin-terminated poly(acryloyl hydrazide) scaf-
fold 4 in two steps (Scheme 1). First, we used the reversible
addition-fragmentation chain transfer (RAFT) polymerization of
acetoxime acrylate (1)
13 in the presence of the biotinylated chain-
transfer agent 2 to obtain polymeric intermediate 3. The activated
acetoxime esters in 3 were then cleanly converted into the
corresponding hydrazides upon treatment with excess hydrazine.
Importantly, NMR and elemental analyses of 4 showed no evidence
that intramolecular cyclization or cross-linking took place during
this step.
Conjugation of a wide range of reducing sugars to 4 proceeded
smoothly under acidic conditions in the presence of aniline
catalyst
14 to provide glycopolymers 5 (Table 1). The closed
† Department of Chemistry, University of California.
‡ Materials Sciences Division, Lawrence Berkeley National Laboratory.
§ The Molecular Foundry, Lawrence Berkeley National Laboratory.
| Department of Molecular and Cell Biology, University of California.
⊥ Howard Hughes Medical Institute, University of California.
Scheme 1. Synthesis of Glycopolymers 5
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obtained glycopolymers containing common mono-, di-, and
trisaccharides in good to excellent yields. The ligation reaction is
reversible, and its efﬁciency depends on the sugar size and the
stability of the resulting conjugate. We found that 1.1 equiv of sugar
at 0.25 M hydrazide group concentration was sufﬁcient to force
the equilibrium effectively toward product formation. The ligation
efﬁciency improved with increasing sugar-to-hydrazide ratio and
leveled out at ∼2 equiv of sugar (Table 1). The glycopolymers are
stable to hydrolysis at pH g 7. Generally, glycans with N-
acetylhexosamine reducing ends showed somewhat diminished
ligation efﬁciencies (Table 1, entries 10-14), presumably as a result
of the increased steric demands of the C2 acetamido group. Notably,
sulfated glycosaminoglycan-like disaccharide building blocks were
also compatible with this ligation strategy (Table 1, entry 14).
Glycopolymers containing complex glycans are readily accessible
using our methodology (Figure 1A). In view of the scant availability
of these complex epitopes, we optimized the ligation conditions
for substoichiometric amounts of the glycan component (0.6 equiv/
hydrazide) (Figure 1A). In agreement with our previous observa-
tions, antigen H and lacto-N-fucopentaose III were efﬁciently
conjugated to the polymer backbone through their reducing glucose
residues (60 and 68% ligation efﬁciency, respectively, based on
glycan), while sialyl N-acetyllactosamine and sialyl Lewisx glycans
bearing N-acetylglucosamine (GlcNAc) at their reducing termini
were incorporated to a lesser extent (20 and 17%, respectively).
To evaluate the speciﬁcities of their interactions with lectins,
we microarrayed polymers 5a-r on streptavidin-coated glass and
tested for binding of Cy5-labeled concanavalin A (ConA), Ricinus
communis I (RCA I), Helix pomatia agglutinin (HPA), and Aleuria
aurantea lectin (AAL) (Figure 1B). As expected, ConA recognized
the terminal R-mannose and R-glucose residues in polymers 5h
and 5i, respectively.
15 Similarly, RCA I identiﬁed polymers 5g and
5l (but not 5q) presenting terminal galactose epitopes.
15 HPA bound
to N-acetylgalactosamine-containing polymer 5k and less strongly
to polymer 5j displaying GlcNAc, a much weaker HPA ligand.
16
Finally, fucose-speciﬁc AAL bound to glycopolymers bearing
fucose (5d), antigen H (5o), lacto-N-fucopentaose (5q), and sialyl
Lewisx (5r), all of which contain the target residue.
15
In summary, we have developed a strategy for the expedient
synthesis of glycopolymers for microarray applications via ligation
of reducing sugars to backbones carrying hydrazide groups and a
surface anchor. We used this methodology to assemble a panel of
biotinylated glycopolymer ligands, which we microarrayed on
streptavidin-coated glass slides. In the microarrays, they were
recognized by lectins according to the structures of their pendant
glycans, offering a promising new platform for multivalent ligand
display in glycan arrays.
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c 12
7 lactose g 75 (95) 80 20 -
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12 N-acetyllactosamine l 42 (42) 86 14 -
13 N,N-diacetylchitobiose m 37 (34) 100
c -
14 chondroitin ∆di-6S n 44 (44) 83
c 17
a l.e. ) ligation efﬁciency for the reaction of 4 with 1.1 (2.0) equiv
of glycan.
b Isomeric ratio determined by 1H NMR analysis.
c The /R
ratio could not be determined. Glycan structures are shown in the
Supporting Information.
Figure 1. Assembly of glycopolymers with complex glycans and microar-
ray display. (A) Conjugation of human milk and blood oligosaccharides
(ligation efﬁciencies based on glycan stoichiometry). (B) Microarrays of
glycopolymers 5a-r on streptavidin-coated glass stained with Cy5-
conjugated ConA, RCA I, HPA, and AAL lectins.
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